Date Filed | Type | Description |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2020 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Granted 4,500 options to buy
@ $2.07, valued at
$9.3k
|
|
05/14/2020 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 22,000 options to buy
@ $0.43, valued at
$9.5k
|
|
06/17/2019 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.635, valued at
$9.5k
|
|
05/15/2019 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 7,000 options to buy
@ $4.02, valued at
$28.1k
|
|
09/21/2018 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 12,000 options to buy
@ $2.56, valued at
$30.7k
|
|
06/13/2018 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $2.7, valued at
$40.5k
|
|
09/12/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2017 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $2.15, valued at
$32.3k
|
|
06/02/2016 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns:
| Granted 7,500 shares
@ $0 |
|
05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/24/2016 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
05/28/2013 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Exercised 2,000 shares
@ $10.64, valued at
$21.3k
Exercised 2,000 restricted stock units
@ $0 Granted 5,000 options to buy
@ $10.73, valued at
$53.7k
Granted 2,500 restricted stock units
@ $0 |
|
06/04/2012 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Bought 1,000 shares
@ $12.46, valued at
$12.5k
Granted 4,000 options to buy
@ $12.56, valued at
$50.2k
Granted 2,000 restricted stock units
@ $0 |
|
09/24/2010 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC
Txns:
| Granted 89,088 options to buy
@ $2.27, valued at
$202.2k
|
|
06/09/2010 |
4
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Granted 5,500 options to buy
@ $14.2, valued at
$78.1k
|
|
06/09/2010 |
3
| MATTINGLY MARTIN A (Director) has filed a Form 3 on ONCOGENEX PHARMACEUTICALS, INC. |
07/22/2009 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC |
01/28/2009 |
4
| MATTINGLY MARTIN A (CEO) has filed a Form 4 on TRIMERIS INC |